US Stock MarketDetailed Quotes

CGTX Cognition Therapeutics

Watchlist
  • 0.629
  • +0.047+8.08%
Trading Aug 8 13:41 ET
25.24MMarket Cap-676P/E (TTM)

Cognition Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cognition Therapeutics Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 8, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.24

-47.97%
Analyst Rating

Buy

Aug 6, 2024

Cognition Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
Aug 8, 20242024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
Aug 8, 20242024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
Mar 26, 20242023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Cognition Therapeutics Earnings Reports

  • Cognition Therapeutics | 10-Q: Quarterly report

    Aug 8 07:19 ET

  • Cognition Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 7 07:49 ET

  • Cognition Therapeutics | 10-K: FY2023 Annual Report

    Mar 26 16:21 ET

  • Cognition Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 07:45 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 6, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg